文献速递乳腺技术与安全US

淋巴-血管双系统超分辨率超声诊断乳腺癌前哨淋巴结转移

Lymphatic and Vascular Dual-System Super-Resolution Ultrasound for Diagnosing Sentinel Lymph Node Metastasis in Breast Cancer: A Prospective Study.
PubMed 文献 · Ultrasound Med Biol · 2026-07-11

本研究前瞻性纳入54例拟行前哨淋巴结活检的乳腺癌患者,行常规腋窝超声及淋巴与血管双系统超分辨率超声。对58枚前哨淋巴结提取定量参数并构建淋巴、血管及双系统整合模型,以组织病理为参考标准。双系统模型AUC达0.962,敏感度95.83%,特异度82.35%,优于单一系统模型及常规超声。

要点

  • 双系统超分辨率超声模型对乳腺癌前哨淋巴结转移有很高的术前诊断效能。
  • 皮质淋巴窦密度比降低、皮质窦最大与平均距离增大提示转移。
  • 皮质血容量增高、最大皮质血管密度比增高及全结平均血流速度降低提示转移。

核心结论

  • 淋巴-血管双系统超分辨率超声整合模型可对乳腺癌前哨淋巴结转移实现高效的非侵入性术前诊断。

研究设计与样本

  • 前瞻性研究,纳入54例拟行前哨淋巴结活检的乳腺癌患者,共分析58枚前哨淋巴结。
  • 研究对象先接受常规腋窝超声,再行淋巴对比增强超分辨率超声和血管对比增强超分辨率超声。
  • 以组织病理学结果为参考标准,评价各模型诊断效能。

关键影像表现/征象

  • 淋巴系统参数中,转移淋巴结皮质淋巴窦密度比较低,皮质淋巴窦最大距离和平均距离较大。
  • 血管系统参数中,转移淋巴结皮质血容量较高,最大皮质血管密度比较高,全淋巴结平均血流速度较低。

诊断标准与关键数值

  • 单因素分析中p<0.05的变量进入多因素logistic回归,分别构建L-CESRUS、V-CESRUS及双系统整合模型。
  • 双系统整合模型AUC为0.962,95%CI为0.920-1.000,p<0.001。
  • 双系统整合模型敏感度为95.83%,特异度为82.35%。
  • L-CESRUS模型AUC为0.880,V-CESRUS模型AUC为0.801。

临床应用与阅片要点

  • 阅片时可将皮质淋巴窦密度比降低和皮质窦距离增大作为淋巴系统提示转移的定量指标。
  • 皮质血容量与最大皮质血管密度比增高、全结平均血流速度降低可作为血管系统提示转移的参考指标。
  • 双系统整合模型较单一血管或淋巴模型及常规超声诊断效能更优,更宜用于术前无创评估。

局限性

  • 样本量较小,仅54例患者、58枚前哨淋巴结。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop and validate a non-invasive diagnostic model for sentinel lymph node (SLN) metastasis in breast cancer using lymphatic and vascular dual-system super-resolution ultrasound (SRUS).

MATERIALS AND METHODS: In this prospective study, 54 patients scheduled for SLN biopsy underwent conventional axillary ultrasound followed by dual-system SRUS, including lymphatic contrast-enhanced SRUS (L-CESRUS) and vascular contrast-enhanced SRUS (V-CESRUS). Quantitative parameters were extracted, and variables with p < 0.05 in univariate analysis were included in multivariate logistic regression to construct three models: L-CESRUS, V-CESRUS, and an integrative dual-system model. Diagnostic performance was evaluated against histopathology using AUC, sensitivity, specificity, and accuracy.

RESULTS: Among 58 SLNs (from 54 patients), 24 (41.4%) were metastatic. Independent predictors included: in the lymphatic system, lower cortical lymphatic sinus density ratio (p = 0.003), larger maximum and mean cortical sinus distances (p = 0.022, p = 0.024); in the vascular system, higher cortical blood volume (p = 0.027), higher maximum cortical vessel density ratio (p = 0.037), and lower whole-node mean blood flow velocity (p = 0.007). The dual-system model achieved an AUC of 0.962 (95% CI: 0.920-1.000, p < 0.001), with 95.83% sensitivity and 82.35% specificity, significantly outperforming L-CESRUS (AUC = 0.880), V-CESRUS (AUC = 0.801), and conventional ultrasound.

CONCLUSION: The integrative dual-system SRUS model enables highly accurate, non-invasive preoperative diagnosis of SLN metastasis in breast cancer.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Li, Wang, Yao, et al. Lymphatic and Vascular Dual-System Super-Resolution Ultrasound for Diagnosing Sentinel Lymph Node Metastasis in Breast Cancer: A Prospective Study. Ultrasound Med Biol. 2026. PMID: 42431777. doi:10.1016/j.ultrasmedbio.2026.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。